Sweden’s Belach Bioteknik has been partnering mostly with researchers and pharma customers to design suited bioreactor systems for biomanufacturing. Most recently, the company has entered the growing cultured meat sector, in which many companies are currently scaling up their production and thus need expertise to get optimal results.
Fermentation fuels ingredient innovation
BackgroundBiotech innovator Biosyntia ApS, the latest addition to the ECBF, is applying proprietary biological processes to produce sustainable nutritional ingredients – a mission that has captured the imagination of seasoned biotech investors and major ingredient players.
Ingenza appoints Steve Jones as new CFO
AppointmentsSteve Jones took over the role of Chief Financial Officer (CFO) at the biotech company Ingenza Ltd (UK) at the beginning of April. He brings many years of experience and expertise in finance, having held a variety of senior positions.
Mosaic Therapeutics closes $28m series A financing
Latest NewsWellcome Sanger Institute spin out Mosaic Therapeutics has closed a $28m series A funding led by Syncona Investment Management Ltd, and Cambridge Innovation Capital.
Carbios SAS set to licence and expand PET recycling
Latest NewsFrench enzymatic polyethylene therephtalate recycler Carbios SAS has published a licensing documentation for global commercial deployment of its biorecycling technology.
Insempra and Axxence launch alpha-ionone
Latest NewsPrecision fermentation specialist Insempra GmbH has inked a supply deal with Axxence Aromatic GmbH for alpha-Ionon, a natural flavour and fragance ingredient.
German-Chinese ADC collaboration
Latest NewsBioNTech has entered the ADC field with an exclusive license and collaboration agreement with China’s DualityBio Ltd for two antibody-drug conjugate (ADC) assets.
Nomi Biotech presents natural additive to preserve probiotics
Latest NewsResearchers from Polish-Japanese Nomi Biotech sp zoo have presented evidence that that probiotic yogurt can be conserved without artificial preservatives.
Algal enzyme synthesizes gasoline building blocks
Latest NewsAn algal photoenzyme that synthesizes medium-chain hydrocarbons – the building blocks of gasoline – is set to boost industrial-scale production of biofuels.
LSP Dementia Fund closes at €260m
Latest NewsEQT Life Sciences has closed the LSP Dementia Fund at approximately €260m, 2.6-fold over the target fund size of €100m.
From lab to industrial scale bioreactors
BackgroundSweden’s Belach Bioteknik has been partnering mostly with researchers and pharma customers to design suited bioreactor systems for biomanufacturing. Most recently, the company has entered the growing cultured meat sector, in which many companies are currently scaling up their production and thus need expertise to get optimal results.